MedTrace Logo

Study of Association of Anti-inflammatory and Anti-rheumatic

NCT02448199 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 375

Last updated 2015-05-19

No results posted yet for this study

Summary

Phase III Study, double-blind, comparing association of anti-inflammatory and anti-rheumatic in 375 subjects with knee osteoarthritis.

Conditions

Interventions

DRUG

Meloxicam and Glucosamine

Experimental

DRUG

Meloxicam

Active Comparator

DRUG

Glucosamine

Active Comparator

Sponsors & Collaborators

  • Eurotrials Brasil Consultores Cientificos Ltda

    collaborator INDUSTRY

  • Zodiac Produtos Farmaceuticos S.A.

    lead INDUSTRY

Principal Investigators

  • Edio Costa, Doctor · CRM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-06-30
Completion
2016-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448199 on ClinicalTrials.gov